Forgot Password

  • Occams Business Research & Consulting Pvt. Ltd

Thank you for your request!

We will soon reach out to you.

Thank you for downloading..!

Contact us for more information.
Home » Healthcare » Medical Devices » HME-2970916
  • Global Bioabsorbable Stents Market-Technologies, Market share and Industry Forecast to 2024

  • Publish: September 2016 | Report Code: HME-2970916

* For discount/customization and buying a particular chapter click here or write to us at sales@occamsresearch.com

Global bioabsorbable stents market is expected to have a CAGR of 44.7% during the forecast period 2016-2023. Bioabsorbable stents are commonly used in the treatment of blocked arteries. They are tiny and expandable mesh tubes that hold arteries open and treat peripheral and coronary artery diseases. Bioabsorbable stents are defined as fully biodegradable stents that are completely absorbed by the human body. The percutaneous coronary intervention, majorly known as angioplasty, is the most effective treatment for peripheral and coronary artery diseases. In this type of procedure, bioabsorbable stents are placed in arteries to keep it open.  There is rise in number of angioplasty procedures due to increasing incidence of cardiovascular diseases which expands the global bio absorbable stents market. Some of the key drivers of bioabsorbable stents market are increasing growth of generic population, increasing risk of coronary and peripheral artery diseases for the generic population. Slow adoption rate of bioabsorbable stents in heart related diseases is the key problem faced by the global bioabsorbable stents, which restraints the growth of the global bioabsorbable stents market. Few more restricting factors of the market are stringent government regulation and cost extensive devices which hinder the growth of the global bioabsorbable stents market. Some of the major opportunities for the market are the rising demand from emerging economies, rising healthcare expenditure in the emerging countries and high risk patients. Challenges faced by the global bioabsorbable stents market are availability of substitute, increasing R&D activities for cell transplantation to treat heart diseases and complications with bioabsorbable stents.

 Source: OBRC Analysis

The global bioabsorbable stents market is majorly segmented on the basis of absorption rate, drugs, applications, end users, materials. On the basis of absorption rate, market is sub-segmented into:

  • Slow absorption stents
  • High absorption stents



On the basis of drugs, market is sub segmented into:

  • Paclitaxel based drugs
  • Limos based drugs



On the basis of application, the market is sub segmented into:

  • Coronary artery disease
  • Peripheral artery disease



On the basis of end users, market is sub segmented into:

  • Hospitals
  • Cardiac centers Hospitals
  • On the basis of materials, market is sub segmented into:
  • Polymeric stents
  • Metallic stents






The revenue for the above application and end-user segments are specific to the global bio absorbable stents market. However, the total revenue of these applications and end-users in general has been excluded from the scope of the report. Also the market revenue has been calculated by summing up application, end-user, absorption rate, drugs and material segments.

Geographically, the global bioabsorbable stents market is segmented into:

  • North America
  • Europe
  • Asia Pacific
  • Rest of the World





North America has the maximum market share of global bioabsorbable stents market due to rise in awareness about the bioabsorbable stents in the treatment of coronary ailments, rising prevalence of obesity, heart attacks and other cardiac diseases. Dominance of major players in this region is also fueling to the growth of the global bioabsorbable stents market. United States represents the largest market for bioabsorbable stents in North American region, followed by Canada. In European region, Italy, Germany and U.K have the largest market share for the global bio absorbable stents market. Rising awareness regarding obesity related health issues and increasing health care expenditures are enhancing the global bioabsorbable stents market. During the forecast period, Asia Pacific region is expected to have fastest growth rate due to increase in public awareness related to various peripheral and coronary artery diseases in the region. The contributors India, China and Japan are expected to be the fastest growing bioabsorbable stents markets in Asia Pacific. Rest of the world is also growing but not at a faster rate. Slow adoption of bioabsorbable stents and lack of knowledge regarding artery diseases are some factors restraining growth in this region.

On the basis of absorption rate, market is divided into slow and high absorption stents. Slow absorption rate stents has registered maximum market share in 2015 owing to the longer effect of medicines and drugs which are being released within the artery. On the basis of application the coronary artery diseases has been increasing rapidly due to growing prevalence of lifestyle oriented diseases such as obesity, heart attacks, strokes, etc., rising geriatric population base is also pushing coronary artery diseases upward. Due to rising coronary artery diseases application, bio absorbable stents witness huge demand. In end user segment hospitals are the major end users of bioabsorbable stents. Rising healthcare standards and infrastructures in hospitals and rising heart diseases patient’s walk-ins in the hospitals are the major factors enhancing the end user segment of global bioabsorbable stents market. The polymeric bioabsorbable stents are majorly used in cardiovascular devices. The use of bioabsorbable polymer in coating reduces thrombotic events and decreases the need for extending dual anti-platelet therapy. Magnesium and iron are the most commonly used metals to make metallic bioabsorbable stents. The factors determining the biocompatibility of these alloys are their solubility and degradation properties. Magnesium bioabsorbable stents are widely used metallic alloy stents in arteries related diseases, as magnesium is one of the essential elements of human body.

The major market players of the global bio absorbable stents market are:

  • ABBOTT LABORATORIES
  • AMARANTH MEDICAL INC.
  • ARTERIAL REMODELING TECHNOLOGIES
  • ARTERIUS LIMITED
  • OTHERS






Detailed analysis of these companies provided in this report comprises of overview, SCOT analysis, product portfolio, strategic initiative and strategic analysis.

These companies use various strategies such as merger & acquisition, collaboration, partnership and product launching. Example: on 28th April 2016, Abbott Laboratories announced the acquisition of St. Jude Medical Inc. This acquisition was a way to bulk up Abbott’s medical-devices business to compete against its rivals Medtronic PLC and Boston Scientific Corp. Abbott also aimed to gain a better negotiating position with its hospital customers, which became larger and more powerful in recent years.

Why to buy the report:

This report will:

  • Provide you the business strategies adopted by market player such as acquisition that is on 28th April 2016, Abbott Laboratories announced the acquisition of St. Jude Medical Inc.
  • Provide in detail the different segments such as application and end-users which affect the global bio absorbable stents market.
  • Provide you the patent analysis of global bio absorbable stents market.
  • Identify and understand the strengths, opportunities, challenges and threats of bio absorbable stents market
  • Provide revenues of major players of the market such as Abbott Laboratories, Johnson & Johnson.
  • Provide you various regulatory policies which affect global bio absorbable stents market.







How we are different from others:

At Occams we provide an extensive portfolio which is comprehensive market analysis along with the market size, market share, and market segmentations. Our report on global bio absorbable stents  market offers the longest chain of market segmentation covering major market segmentation based on absorption rate, drugs, application ,end users and material. The report tracks the major market trends in the global bio absorbable stents market such as technological advancements and innovative products in the medical field.  For each market segments covered in global bio absorbable stents market report, we provide opportunity matrix, and DRO analysis, that enable the clear growth assessment across each market segment. The report discusses competitive landscape of the bio absorbable stents industry, with giving extensive strategy analysis of more than 15 companies. Moreover, the report discusses various models such as 360 degree analysis, See Saw analysis, and Porter five force model and so on. For the high level analysis in the report we provide a comparative analysis of historic and current year data. 

Key findings of the global bio absorbable stents market:

  • North America held the largest revenue share in 2016.
  • Acquisition is the key strategy adopted by the various market players of global bio absorbable stents market.

1.       INTRODUCTION

1.1. EXECUTIVE SUMMARY

1.2. ESTIMATION METHODOLOGY

2.       MARKET OVERVIEW

2.1. GLOBAL BIOABSORBABLE MARKET : EVOLUTION & TRANSITION

2.2. MARKET DEFINITION & SCOPE

2.3. INDUSTRY STRUCTURE

2.4. TOTAL MARKET ANALYSIS

2.4.1.        TOP 5 FINDINGS

2.4.2.        TOP 5 OPPORTUNITY MARKETS

2.4.3.        TOP 5 COMPANIES

2.4.4.        TOP 3 COMPETITIVE STRATEGIES

2.5. ESTIMATION ANALYSIS

2.6. STRATEGIC ANALYSIS

2.6.1.        INVESTMENT VS. ADOPTION MODEL

2.6.2.        360-DEGREE INDUSTRY ANALYSIS

2.6.3.        PORTERS 5 FORCE MODEL

2.6.4.        SEE-SAW ANALYSIS

2.6.5.        CONSUMER ANALYSIS AND KEY BUYING CRITERIA

2.7. COMPETITIVE ANALYSIS

2.7.1.        KEY STRATEGIES & ANALYSIS

2.7.2.        MARKET SHARE ANALYSIS & TOP COMPANY ANALYSIS

2.8. STRATEGIC RECOMMENDATIONS & KEY CONCLUSIONS

2.8.1.        INVESTMENT OPPORTUNITIES BY REGIONS

2.8.2.        OPPORTUNITIES IN EMERGING APPLICATIONS

2.8.3.        INVESTMENT OPPORTUNITY IN FASTEST GROWING SEGMENT

3.       MARKET DETERMINANTS

3.1. MARKET DRIVERS

3.1.1.        INCREASING GROWTH OF GERIATRIC POPULATION

3.1.2.        INCREASING RISK OF CORONARY ARTERY & PERIPHERAL ARTERY DISEASES IN THE ELDERLY POPULATION

3.1.3.        INCREASING NBUMBER OF HEART FAILURE AND DIABETES CASES

3.1.4.        STRONG PRODUCT PIPELINES

3.1.5.         RISING TECHNOLOGICAL ADVANCEMENTS

3.2. MARKET RESTRAINTS

3.2.1.        SLOW ADOPTION RATE

3.2.2.         STRINGENT GOVERNMENT REGULATIONS

3.3. HIGH COST OF DEVICES

3.4. MARKET OPPORTUNITIES

3.4.1.        RISING DEMAND FROM EMERGING ECONOMIES FOR THE MARKET PLAYERS

3.4.2.        TARGET HIGH RISK PATIENTS

3.4.3.        RISING HEALTHCARE EXPENDITURE IN THE EMERGING COUNTRIES

3.5. MARKET CHALLENGES

3.5.1.        AVAILIBILITY OF SUBSTITUTE

3.5.2.        INCREASING R&D ACTIVITIES FOR THE CELL TRANSPLANTATION TO TREAT THE HEART DIASEASE

3.5.3.         COMPLICATIONS WITH BIOABSORBABLE STENTS

3.5.4.         PARENT MARKET

3.5.5.         COMPETITORS MARKET

3.5.6.        ALTERNATIVE MARKET

4.      GLOBAL BIOABSORBABLE MARKET BY ABSORPTION RATE

4.1. MARKET DEFINITION AND SCOPE

4.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY

4.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS

4.4.  OPPORTUNITY MATRIX

4.5. MARKET SEGMENTATION

4.5.1.      GLOBAL BIOABSORBABLE STENTS MARKET BY SLOW ABSORPTION STENTS  AMARKET

4.5.1.1.  ADOPTION SCENARIO & MARKET DETERMINANTS

4.5.1.2.  MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

4.5.1.3.  MARKET PARTICIPANTS AND PRODUCTS

4.5.1.4.  KEY CONCLUSIONS

4.5.2.      GLOBAL HIGH ABSORPTION STENTS ANSORBTION RATE MARKET

4.5.2.1.  ADOPTION SCENARIO & MARKET DETERMINANTS

4.5.2.2.  MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

4.5.2.3.  MARKET PARTICIPANTS AND PRODUCTS

4.5.2.4.  KEY CONCLUSIONS

5.      GLOBAL  BIOABSORBABLE STENTS  MARKET BY DRUGS

5.1. MARKET DEFINITION AND SCOPE

5.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY

5.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS

5.4.  OPPORTUNITY MATRIX

5.5. MARKET SEGMENTATION

5.5.1.      GLOBAL PACLITAXEL  DRUGS MARKET

5.5.1.1.  ADOPTION SCENARIO & MARKET DETERMINANTS

5.5.1.2.  MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

5.5.1.3.  MARKET PARTICIPANTS AND PRODUCTS

5.5.1.4.  KEY CONCLUSIONS

5.5.2.      GLOBAL LIMUS BASED DRUGS MARKET

5.5.2.1.  ADOPTION SCENARIO & MARKET DETERMINANTS

5.5.2.2.  MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

5.5.2.3.  MARKET PARTICIPANTS AND PRODUCTS

5.5.2.4.  KEY CONCLUSIONS

6.      GLOBAL BIOABSORBABLE STENTS  MARKET BY APPLICATIONS

6.1. MARKET DEFINITION AND SCOPE

6.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY

6.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS

6.4.  OPPORTUNITY MATRIX

6.5. MARKET SEGMENTATION

6.5.1.      GLOBAL CORONARY ARTERY APPLICATION  MARKET

6.5.1.1.  ADOPTION SCENARIO & MARKET DETERMINANTS

6.5.1.2.  MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

6.5.1.3.  MARKET PARTICIPANTS AND PRODUCTS

6.5.1.4.  KEY CONCLUSIONS

6.5.2.      GLOBAL PERIPHERAL ARTERY DISEASE APPLICATION MARKET

6.5.2.1.  ADOPTION SCENARIO & MARKET DETERMINANTS

6.5.2.2.  MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

6.5.2.3.  MARKET PARTICIPANTS AND PRODUCTS

6.5.2.4.  KEY CONCLUSIONS

7.      GLOBAL BIOABSORBABLE STENTS  MARKET BY END USERS

7.1. MARKET DEFINITION AND SCOPE

7.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY

7.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS

7.4.  OPPORTUNITY MATRIX

7.5. MARKET SEGMENTATION

7.5.1.      GLOBAL HOSPITALS END USER  MARKET

7.5.1.1.  ADOPTION SCENARIO & MARKET DETERMINANTS

7.5.1.2.  MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

7.5.1.3.  MARKET PARTICIPANTS AND PRODUCTS

7.5.1.4.  KEY CONCLUSIONS

7.5.2.      GLOBAL CARDIAC CENTERS END USER MARKET

7.5.2.1.  ADOPTION SCENARIO & MARKET DETERMINANTS

7.5.2.2.  MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

7.5.2.3.  MARKET PARTICIPANTS AND PRODUCTS

7.5.2.4.  KEY CONCLUSIONS

8.       GLOBAL BIOABSORBABLE STENTS  MARKET BY MATERIALS

8.1. MARKET DEFINITION AND SCOPE

8.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY

8.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS

8.4.  OPPORTUNITY MATRIX

8.5. MARKET SEGMENTATION

8.6.                     GLOBAL BIOABSORBABLE STENTS MARKET BY POLYMERIC STENTS

8.6.1.1.  ADOPTION SCENARIO & MARKET DETERMINANTS

8.6.1.2.  MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

8.6.1.3.  MARKET PARTICIPANTS AND PRODUCTS

8.6.1.4.  KEY CONCLUSIONS

8.7.                     GLOBAL BIOABSORBABLE STENTS MARKET BY METALLIC STENTS

8.7.1.1.  ADOPTION SCENARIO & MARKET DETERMINANTS

8.7.1.2.  MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

8.7.1.3.  MARKET PARTICIPANTS AND PRODUCTS

8.7.1.4.  KEY CONCLUSIONS

 

9.       COMPETITIVE LANDSCAPE

9.1. KEY STRATEGIES

9.1.1.        LIST OF MERGERS AND ACQUISITION

9.1.2.        LIST OF JOINT VENTURES

9.1.3.        LIST OF PRODUCT LAUNCHES

9.1.4.        LIST OF PARTNERSHIPS

10.   GEOGRAPHIC ANALYSIS

10.1.                  DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY

10.2.                  COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS

10.3.                  OPPORTUNITY MATRIX

10.4.                  GLOBAL BIOABSORBABLE MARKET BY REGION 2015-2024  

10.4.1.  NORTH AMERICA

10.4.1.1.                      INDUSTRY ANALYSIS 2015-2024 ($ MILLION)

10.4.1.2.                      TOP COUNTRY ANALYSIS

10.4.1.2.1.  U.S.

10.4.1.2.1.1.           MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

10.4.1.2.1.2.           MARKET PARTICIPANTS AND PRODUCTS

10.4.1.2.1.3.           KEY CONCLUSIONS

10.4.1.2.2.  CANADA

10.4.1.2.2.1.           MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

10.4.1.2.2.2.           MARKET PARTICIPANTS AND PRODUCTS

10.4.1.2.2.3.           KEY CONCLUSIONS

10.4.2.  EUROPE

10.4.2.1.                      INDUSTRY ANALYSIS 2015-2024 ($ MILLION)

10.4.2.2.                      TOP COUNTRY ANALYSIS

10.4.2.2.1.  UK

10.4.2.2.1.1.           MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

10.4.2.2.1.2.           MARKET PARTICIPANTS AND PRODUCTS

10.4.2.2.1.3.           KEY CONCLUSIONS

10.4.2.2.2.  FRANCE

10.4.2.2.2.1.           MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

10.4.2.2.2.2.           MARKET PARTICIPANTS AND PRODUCTS

10.4.2.2.2.3.           KEY CONCLUSIONS

10.4.2.2.3.  GERMANY

10.4.2.2.3.1.           MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

10.4.2.2.3.2.           MARKET PARTICIPANTS AND PRODUCTS

10.4.2.2.3.3.           KEY CONCLUSIONS

10.4.2.2.4.  SPAIN

10.4.2.2.4.1.           MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

10.4.2.2.4.2.           MARKET PARTICIPANTS AND PRODUCTS

10.4.2.2.4.3.           KEY CONCLUSIONS

10.4.2.2.5.  REST OF EUROPE

10.4.2.2.5.1.           MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

10.4.2.2.5.2.           KEY  PLAYERS & KEY PRODUCTS

10.4.2.2.5.3.           KEY CONCLUSIONS

10.4.3.  ASIA PACIFIC

10.4.3.1.                      INDUSTRY ANALYSIS 2015-2024 ($ MILLION)

10.4.3.2.                      TOP COUNTRY ANALYSIS

10.4.3.2.1.  CHINA

10.4.3.2.1.1.           MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

10.4.3.2.1.2.           MARKET PARTICIPANTS AND PRODUCTS

10.4.3.2.1.3.           KEY CONCLUSIONS

10.4.3.2.2.  INDIA

10.4.3.2.2.1.           MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

10.4.3.2.2.2.           MARKET PARTICIPANTS AND PRODUCTS

10.4.3.2.2.3.           KEY CONCLUSIONS

10.4.3.2.3.  JAPAN

10.4.3.2.3.1.           MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

10.4.3.2.3.2.           MARKET PARTICIPANTS AND PRODUCTS

10.4.3.2.3.3.           KEY CONCLUSIONS

10.4.3.2.4.  AUSTRALIA

10.4.3.2.4.1.           MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

10.4.3.2.4.2.           KEY  PLAYERS & KEY PRODUCTS

10.4.3.2.4.3.           KEY CONCLUSIONS

10.4.3.2.5.  REST OF ASIA PACIFIC

10.4.3.2.5.1.           MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

10.4.3.2.5.2.           KEY  PLAYERS & KEY PRODUCTS

10.4.3.2.5.3.           KEY CONCLUSIONS

10.4.4.  ROW

10.4.4.1.                      INDUSTRY ANALYSIS 2015-2024 ($ MILLION)

10.4.4.2.                      TOP COUNTRY ANALYSIS

10.4.4.2.1.  LATIN AMERICA

10.4.4.2.1.1.           MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

10.4.4.2.1.2.           MARKET PARTICIPANTS AND PRODUCTS

10.4.4.2.1.3.           KEY CONCLUSIONS

10.4.4.2.2.  MIDDLE EAST & AFRICA

10.4.4.2.2.1.           MARKET ESTIMATIONS AND FORECASTS 2015-2024 ($ MILLION)

10.4.4.2.2.2.           MARKET PARTICIPANTS AND PRODUCTS

10.4.4.2.2.3.           KEY CONCLUSIONS

11.   COMPANY PROFILES

11.1.                  ABBOTT LABORATORIES  (U.S.)

11.1.1.     OVERVIEW

11.1.2.   PRODUCT PORTFOLIO

11.1.3.   STRATEGIC INITIATIVES

11.1.4.   SCOT ANALYSIS

11.1.5.   STRATEGIC ANALYSIS

11.2.                  AMARANTH MEDICAL INC. (U.S.)

11.2.1.   OVERVIEW

11.2.2.   PRODUCT PORTFOLIO

11.2.3.   STRATEGIC INITIATIVES

11.2.4.   SCOT ANALYSIS

11.2.5.   STRATEGIC ANALYSIS

11.3.                  ARTERIAL REMODELING TECHNOLOGIES (UK)

11.3.1.   OVERVIEW

11.3.2.   PRODUCT PORTFOLIO

11.3.3.   STRATEGIC INITIATIVES

11.3.4.   SCOT ANALYSIS

11.3.5.   STRATEGIC ANALYSIS

11.4.                  BOSTON SCIENTIFIC CORP. (US)

11.4.1.   OVERVIEW

11.4.2.   PRODUCT PORTFOLIO

11.4.3.   STRATEGIC INITIATIVES

11.4.4.   SCOT ANALYSIS

11.4.5.   STRATEGIC ANALYSIS

11.5.                  ELIXIR MEDICAL CORPORATION (US)

11.5.1.   OVERVIEW

11.5.2.   PRODUCT PORTFOLIO

11.5.3.   STRATEGIC INITIATIVES

11.5.4.   SCOT ANALYSIS

11.5.5.   STRATEGIC ANALYSIS

11.6.                  JOHNSON & JOHNSON (US)

11.6.1.   OVERVIEW

11.6.2.   PRODUCT PORTFOLIO

11.6.3.   STRATEGIC INITIATIVES

11.6.4.   SCOT ANALYSIS

11.6.5.   STRATEGIC ANALYSIS

11.7.                   KYOTO MEDICAL PLANNING CO. LTD. (JAPAN)

11.7.1.   OVERVIEW

11.7.2.   PRODUCT PORTFOLIO

11.7.3.   STRATEGIC INITIATIVES

11.7.4.   SCOT ANALYSIS

11.7.5.   STRATEGIC ANALYSIS

11.8.                  MEDTRONIC INC

11.8.1.   OVERVIEW

11.8.2.   PRODUCT PORTFOLIO

11.8.3.   STRATEGIC INITIATIVES

11.8.4.   SCOT ANALYSIS

11.8.5.   STRATEGIC ANALYSIS

11.9.                  MERIL LIFE SCIENCES28

11.9.1.   OVERVIEW

11.9.2.   PRODUCT PORTFOLIO

11.9.3.   STRATEGIC INITIATIVES

11.9.4.   SCOT ANALYSIS

11.9.5.   STRATEGIC ANALYSIS

11.10.              SAHAJANAND MEDICAL TECHNOLOGY (PART OF SAHAJANAND GROUP OF COMPANIES) (INDIA)

11.10.1.                       OVERVIEW

11.10.2.                       PRODUCT PORTFOLIO

11.10.3.                       STRATEGIC INITIATIVES

11.10.4.                       SCOT ANALYSIS

11.10.5.                       STRATEGIC ANALYSIS

11.11.              TEPHA INC (US)

11.11.1.                       OVERVIEW

11.11.2.                       PRODUCT PORTFOLIO

11.11.3.                       STRATEGIC INITIATIVES

11.11.4.                       SCOT ANALYSIS

11.11.5.                       STRATEGIC ANALYSIS

11.12.              XENOGENICS CORPORATION (A SUBSIDIARY OF MULTICELL TECHNOLOGIES INC.) (US)

11.12.1.                       OVERVIEW

11.12.2.                       PRODUCT PORTFOLIO

11.12.3.                       STRATEGIC INITIATIVES

11.12.4.                       SCOT ANALYSIS

11.12.5.                       STRATEGIC ANALYSIS

11.13.              STENTYS S.A.S. (FRANCE)

11.13.1.                       OVERVIEW

11.13.2.                       PRODUCT PORTFOLIO

11.13.3.                       STRATEGIC INITIATIVES

11.13.4.                       SCOT ANALYSIS

11.13.5.                       STRATEGIC ANALYSIS

11.14.              BIOABSORBABLE THERAPEUTICS, INC. (US)

11.14.1.                       OVERVIEW 

11.14.2.                       PRODUCT PORTFOLIO

11.14.3.                       STRATEGIC INITIATIVES

11.14.4.                       SCOT ANALYSIS

11.14.5.                       STRATEGIC ANALYSIS

LIST OF TABLES

1.       GLOBAL BIOABSORBABLE MARKET BY ABSORPTION RATE 2015-2024 ($ MILLION)

2.       GLOBAL SLOW ABSORPTION ABSORPTION MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)

3.       GLOBAL HIGH ABSORPTION ABSORPTION  MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)

4.       GLOBAL BIOABSORBABLE MARKET BY DRUGS  2015-2024 ($ MILLION)

5.       GLOBAL PACLITAXEL ABSORPTION MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)

6.       GLOBAL LIMUS BASED DRUGS ABSORPTION MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)

7.       GLOBAL BIOABSORBABLE MARKET BY APPLICATIONS 2015-2024 ($ MILLION)

8.       GLOBAL CORONARY ARTERY DISEASE APPLICTION MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)

9.       GLOBAL PERIPHERAL ARTERY DISEASE APPLICATION MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)

10.   GLOBAL BIOABSORBABLE MARKET BY END USERS 2015-2024 ($ MILLION)

11.   GLOBAL CARDIAC CENTERS END USER  BY GEOGRAPHY 2015-2024 ($ MILLION)

12.   GLOBAL BIOABSORBABLE MARKET BY MATERIALS  2015-2024 ($ MILLION)

13.   GLOBAL POLYMERIC STENTS  BY GEOGRAPHY 2015-2024 ($ MILLION)

14.    GLOBAL METALLIC STENTS BY GEOGRAPHY 2015-2024 ($ MILLION)

15.   NORTH AMERICA BIOABSORBABLE MARKET 2015-2024 ($ MILLION)

16.   EUROPE BIOABSORBABLE MARKET 2015-2024 ($ MILLION)

17.   ASIA PACIFIC BIOABSORBABLE MARKET 2015-2024 ($ MILLION)

18.   REST OF THE WORLD BIOABSORBABLE MARKET 2015-2024 ($ MILLION)

19.   NORTH AMERICA BIOABSORBABLE MARKET BY ABSORPTION RATE 2015-2024 ($ MILLION)

20.   EUROPE BIOABSORBABLE MARKET BY ABSORPTION RATE 2015-2024 ($ MILLION)

21.   ASIA PACIFIC BIOABSORBABLE MARKET BY ABSORPTION RATE2015-2024 ($ MILLION)

22.   REST OF THE WORLD FINTECH BLOCKCHAINMARKET BY ABSORPTION RATE 2015-2024 ($ MILLION)

23.   NORTH AMERICA BIOABSORBABLE  MARKET BY DRUGS 2015-2024 ($ MILLION)

24.   EUROPE BIOABSORBABLE MARKET BY DRUGS 2015-2024 ($ MILLION)

25.   ASIA PACIFIC BIOABSORBABLE  MARKET BY DRUGS 2015-2024 ($ MILLION)

26.   REST OF THE WORLD BIOABSORBABLE  MARKET BY DRUGS 2015-2024 ($ MILLION)

27.   NORTH AMERICA BIOABSORBABLE MARKET BY APPLICATIONS  2015-2024 ($ MILLION)

28.   EUROPE BIOABSORBABLE MARKET BY APPLICATIONS  2015-2024 ($ MILLION)

29.   ASIA PACIFIC BIOABSORBABLE MARKET BY APPLICATIONS 2015-2024 ($ MILLION)

30.   REST OF THE WORLD BIOABSORBABLE MARKET BY APPLICATIONS 2015-2024 ($ MILLION)

31.   NORTH AMERICA BIOABSORBABLE MARKET BY END USERS2015 -2024 ($ MILLION)

32.   EUROPE BIOABSORBABLE MARKET BY END USERS 2015 -2024 ($ MILLION)

33.    

34.   ASIA PACIFIC BIOABSORBABLE BY END USERS MARKET 2015-2024 ($ MILLION)

35.   REST OF THE WORLD BIOABSORBABLE BY END USERS MARKET 2015-2024 ($ MILLION)

36.   NORTH AMERICA BIOABSORBABLE MARKET BY MATERIALS 2015 -2024 ($ MILLION)

37.   EUROPE BIOABSORBABLE MARKET BY MATERIALS 2015 -2024 ($ MILLION)

38.    

39.   ASIA PACIFIC BIOABSORBABLE BY MATERIALS 2015-2024 ($ MILLION)

40.   REST OF THE WORLD BIOABSORBABLE BY MATERIALS  2015-2024 ($ MILLION)

41.   UNITED STATES BIOABSORBABLE  MARKET BY ABSORPTION RATE 2015-2024 ($ MILLION)

42.   UNITED STATES BIOABSORBABLE  MARKET BY DRUGS  2015-2024 ($ MILLION)

43.   UNITED STATES BIOABSORBABLE  MARKET Y APPLICATIONS  2015-2024 ($ MILLION)

44.   UNITED STATES BIOABSORBABLE  MARKET  BY END USERS 2015-2024 ($ MILLION)

45.    

46.   CANADA STATES BIOABSORBABLE  MARKET BY ABSORPTION RATE 2015-2024 ($ MILLION)

47.   CANADA BIOABSORBABLE  MARKET BY DRUGS  2015-2024 ($ MILLION)

48.   CANADA BIOABSORBABLE  MARKET Y APPLICATIONS  2015-2024 ($ MILLION)

49.   CANADA BIOABSORBABLE  MARKET  BY END USERS 2015-2024 ($ MILLION)

50.   UK STATES BIOABSORBABLE  MARKET BY ABSORPTION RATE 2015-2024 ($ MILLION)

LIST OF FIGURES

1.       GLOBAL BIOABSORBABLE MARKET BY ABSORPTION RATE 2015-2024 ($ MILLION)

2.       GLOBAL SLOW ABSORPTION ABSORPTION MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)

3.       GLOBAL HIGH ABSORPTION ABSORPTION  MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)

4.       GLOBAL BIOABSORBABLE MARKET BY DRUGS  2015-2024 ($ MILLION)

5.       GLOBAL PACLITAXEL ABSORPTION MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)

6.       GLOBAL LIMUS BASED DRUGS ABSORPTION MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)

7.       GLOBAL BIOABSORBABLE MARKET BY APPLICATIONS 2015-2024 ($ MILLION)

8.       GLOBAL CORONARY ARTERY DISEASE APPLICTION MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)

9.       GLOBAL PERIPHERAL ARTERY DISEASE APPLICATION MARKET BY GEOGRAPHY 2015-2024 ($ MILLION)

10.   GLOBAL BIOABSORBABLE MARKET BY END USERS 2015-2024 ($ MILLION)

11.   GLOBAL CARDIAC CENTERS END USER  BY GEOGRAPHY 2015-2024 ($ MILLION)

12.   GLOBAL BIOABSORBABLE MARKET BY MATERIALS  2015-2024 ($ MILLION)

13.   GLOBAL POLYMERIC STENTS  BY GEOGRAPHY 2015-2024 ($ MILLION)

14.    GLOBAL METALLIC STENTS BY GEOGRAPHY 2015-2024 ($ MILLION)

15.   UNITED STATES (U.S.) BIOABSORBABLE MARKET 2015-2024 ($ MILLION)

16.   CANADA BIOABSORBABLE MARKET 2015-2024 ($ MILLION)

17.   UNITED KINGDOM (UK) BIOABSORBABLE MARKET 2015-2024 ($ MILLION)

18.   FRANCE BIOABSORBABLE MARKET 2015-2024 ($ MILLION)

19.   GERMANY BIOABSORBABLE MARKET 2015-2024 ($ MILLION)

20.   SPAIN BIOABSORBABLE MARKET 2015-2024 ($ MILLION)

21.   ROE BIOABSORBABLE MARKET 2015-2024 ($ MILLION)

22.   CHINA BIOABSORBABLE MARKET 2015-2024 ($ MILLION)

23.   INDIA BIOABSORBABLE MARKET 2015-2024 ($ MILLION)

24.   JAPAN BIOABSORBABLE MARKET 2015-2024 ($ MILLION)

25.   AUSTRALIA BIOABSORBABLE MARKET 2015-2024 ($ MILLION)

26.   ROAPAC BIOABSORBABLE MARKET 2015-2024 ($ MILLION)

27.   LATIN AMERICA BIOABSORBABLE MARKET 2015-2024 ($ MILLION)

28.   MENA BIOABSORBABLE MARKET 2015-2024 ($ MILLION) 

 

 

FAQ

How can I purchase a report?
We offer an easy way to purchase any report of your choice from various domains that we offer. You can easily search for your desired reports by simply using the search bar on our website's home page. For multiple purchases, you can add reports to the shopping cart, fill a detail form and check out. We accept payments though authentic and trusted payment gateways which accept all major credit cards.
How safe is to use my credit card? Is my information secure?
We ensure complete safety to all online transactions made by credit cards. We use most secure encryption technology available today for the electronic transactions and all our credit card sales are secured with an SSL technology. Your information is highly secure and confidential.
Can I get a discount?
We send discount offers through email as per your request. In case you would like to receive discounts, please sign up for our newsletter.
I want to buy only a chapter. I don't need complete report.
Yes you can buy your desired chapter/page or the entire report, by just clicking on the table of contents in any report and selecting chapter of your interest. We do have separate pricing for chapters/reports/excel sheets/presentation pages etc.
Can I get reports on my desired topic specially which is not available in your current portfolio?
Do call us or mail us the topic of your preference. Our dedicated team on analysts will prepare a report as per your preference and requirements.
When do I get access to the report(s) that I have purchased?
We will email you your purchased report right after we receive your payment through any of the payment options.
Will I receive any invoice for my purchase?
Yes we will email you invoice/payment confirmation with the order details once we receive your payment.
In what format will the reports be available in?
All the reports will be available in PDF format for download.

Request for Sample

CONNECT WITH US

Occams Business Research & Consulting Pvt. Ltd.

Landline: 0731 4042636 

Handheld: +91 8390547755

Email: info@occamsresearch.com

 

 

Go To Top
viewthroughconversion